Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients-Reference-Cited by-同舟云学术

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients

Published:2012-09-26 Issue:1 Volume:13 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Kanda Eiichiro,Yoshida Masayuki,Sasaki Sei

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/article/10.1186/1471-2369-13-122/fulltext.html

Reference34 articles.

1. Pøodenphant J, Nielsen VA, Riis BJ, Gotfredsen A, Christiansen C: Bone mass, bone structure and vertebral fractures in osteoporotic patients. Bone. 1987, 8 (3): 127-130. 10.1016/8756-3282(87)90010-X.

2. Riggs BL, Melton LJ: Involutional osteoporosis. N Engl J Med. 1986, 314 (26): 1676-1686. 10.1056/NEJM198606263142605.

3. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR, et al: Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007, 167 (2): 133-139. 10.1001/archinte.167.2.133.

4. Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, et al: Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2007, 18 (1): 282-286. 10.1681/ASN.2006050546.

5. Nickolas TL, McMahon DJ, Shane E: Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006, 17 (11): 3223-3232. 10.1681/ASN.2005111194.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Classical Effects of FGF23: Molecular and Clinical Features;International Journal of Molecular Sciences;2024-04-30

2. Fibroblast growth factor 23 and its role in bone diseases;Growth Factors;2023-10-31

3. Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients;Journal of Clinical Medicine;2023-09-30

4. Longitudinal Measurements of FGF23, Sarcopenia, Frailty and Fracture in Older Community Dwelling Women;The Journal of Frailty & Aging;2023

5. Biomarkers of Bone Remodeling;Clinical and Laboratory Medicine Textbook;2023